Cancer | Skip to main content


11-21-2022 | Cancer | News

Type 2 diabetes linked to advanced stage at cancer diagnosis

Having type 2 diabetes increases a person’s risk for a cancer being already metastatic at the point of diagnosis, shows an EPIC analysis.

11-17-2022 | Cancer | News

Sex differences in diabetes-linked kidney cancer risk

Diabetes has a stronger association with the risk for kidney cancer in women than men, despite men being overall more likely to develop the malignancy, shows a nationwide cohort study from Korea.

09-30-2022 | Cancer | News

Age at type 2 diabetes diagnosis impacts link with pancreatic cancer risk

Chinese people with new-onset type 2 diabetes have a significantly increased risk for pancreatic cancer relative to the general population, particularly when they are diagnosed at a young age, study findings indicate.

08-08-2022 | Insulin | News

Daily insulin dose may be linked to cancer risk in type 1 diabetes

People with type 1 diabetes who take a higher daily dose of insulin may have an increased risk for cancer compared with those on lower doses, US researchers report.

12-13-2021 | Metabolic surgery | News

Weight-loss surgery associated with decreased cancer risk in obese people with type 2 diabetes

Findings from the prospective Swedish Obese Subjects study suggest that bariatric surgery in people with concomitant type 2 diabetes and obesity is linked to a lower cancer incidence than conventional obesity treatment.

10-13-2020 | Metabolic surgery | News

Bariatric surgery cuts pancreatic cancer risk in obese individuals with diabetes

Bariatric surgery is associated with a reduced prevalence of pancreatic cancer in obese individuals with type 2 diabetes, suggest findings from a population-based study presented at UEG Week Virtual 2020.

09-10-2020 | Cancer | News

New-onset type 2 diabetes accompanied by weight loss may point to pancreatic cancer risk

Type 2 diabetes and weight loss are independently associated with an increased risk for pancreatic cancer, and this risk is further elevated when weight loss occurs together with recent-onset diabetes, according to results from a cohort study.

Tablet device showing the chemical structure of Metformin

06-16-2020 | ADA 2020 | Conference coverage | News

DPPOS: No change to cancer risk with long-term metformin use

Among the latest findings from the DPP Outcomes Study is that long-term use of metformin does not affect the risk for cancer.